Gimv

About Gimv

Gimv is an alternative investment platform with capital deployed across 1 active fund vehicles, headquartered in Brussels. The firm deploys capital across European mid and small-cap businesses spanning TMT, consumer, healthcare, energy, software and industrials.

Investment thesis

The platform combines complementary investment strategies, deploying capital across TMT, consumer, healthcare, energy, software and industrials businesses in Belgium and the Benelux region. Multi-strategy capital deployment enables flexibility across the business lifecycle, with the partnership culture supporting management teams through growth, transmission and selective M&A across multiple fund vintages and asset classes.

Recent activity

Recent realised exits include Arplas Systems (TMT, 2026), ALT Technologies (TMT, 2026), Awelando Gruppe (TMT, 2026) and ImCheck Therapeutics (TMT, 2025). The platform tracks 1 dedicated investment vehicle, 60 active portfolio companies and 97 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €29/month.